Interferência da circulação extracorpórea no despertar da anestesia de pacientes submetidos à revascularização do miocárdio
Extracorporeal circulation interference on emergence from anesthesia in patients submitted to myocardial revascularization
Ricardo Antonio Guimarães Barbosa; Luiz Marcelo Sá Malbouisson; Luciana Moraes dos Santos; Marilde de Albuquerque Piccioni; Maria José Carvalho Carmona
Resumo
Palavras-chave
Abstract
Keywords
References
Barbosa RAG, Santos SRCJ, White PF. Effects of cardiopulmonary bypass on propofol pharmacokinetics and bispectral index during coronary surgery. Clinics. 2009;64:215-221.
Mets B. The pharmacokinetics of anesthetic drugs and adjuvants during cardiopulmonary bypass. Acta Anaesthesiol Scand. 2000;44:261-273.
Gouke CR, Keaveny JP, Kay B, Healy TE, Ryan M. The effect of cardiopulmonary bypass on the pharmacokinetics of drugs. Clin Pharmacokinet. 1982;7:234-251.
Buylaert WA, Herregods LL, Mortier EP, Bogaert MG. Cardiopulmonary bypass and the pharmacokinetics of drugs. . 1989;17:10-26.
Wood M. Plasma drug binding: implications for anesthesiologists. Anesth Analg. 1979;65:786-804.
Wood M. Plasma drug binding: implications for anesthesiologists. Anesth Analg. 1986;65:786-804.
Hiraoka H, Yamamoto K, Morita T, Goto F, Horiuchi R. Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in reponse to altered plasma binding. Clin Pharmacol Ther. 2004;75:324-330.
Bailey JM, Mora CT, Shafer SL. Pharmacokinetics of propofol in adult patients undergoing coronary revascularization. Anesthesiology. 1996;84:1288-1297.
White PF. Intravenous anesthesia ana analgesia: what is the role of target-controlled infusion (TCI). J Clin Anesth. 1996;8:26-28.
Massey NJ, Sherry KM, Oldroyd S, Peaccock JE. Pharmacokinetics of infusion of propofol during cardiac surgery. Br J Anaesth. 1990;65:475-479.
Lee HS, Khoo YM, Chua BC, Tan SS, Chew SL. Pharmacokinetics of propofol infusion in Asian patients undergoing coronary artery bypass grafting. Ther Drug Monit. 1995;17:336-341.
Hammaren E, Yli-Hankala A, Rosenberg PH, Hynynem M. Cardiopulmonary bypass-induced changes in plasma concentrations of propofol and in auditory evoked potentials. Br J Anaesth. 1996;77:360-364.
Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974;2:656-659.
Fisher DM. Development and clinical application of electroencephalographic Bispectrum monitoring. Anesthesiology. 2000;93:1336-1344.
Sigl JC, Chamoun NG. An introduction to bispectral analysis for the electroencephalogram. J Clin Monit. 1994;10:392-404.
White PF. Intravenous anesthesia and analgesia: what is the role of target-controlled infusion (TCI). J Clin Anesth. 1996;8:26-28.
Kenny GNC, Sutcliffe N. European perspective. Textbook of intravenous anesthesia. 1997:527-537.
Glass PSA, Markhan K, Ginsberg B, Hawkins ED. Propofol concentrations required for surgery. Anesthesiology. 1989;71:A273.
Yoshitani H, Takeuchi M, Sakamoto K, Akasaka T, Yoshida K, Yoshikawa J. Effect of one or more co-morbid conditions on diagnostic accuracy of coronary flow velocity reserve for detecting significant left anterior descending coronary stenosis. Heart. 2005;91:1294-1298.
Lysakowski C, Dumont L, Pellegrini M, Clergue F, Tassony E. Effects of fentanyl, alfentanil, remifentanil and sufentanil on loss of consciousness and bispectrum index during propofol induction of anaesthesia. Br J Anaesth. 2001;86:523-527.